Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Pediatric Oncology

The First Steps: Understanding Your Child's Diagnosis

At a Glance

Neuroblastoma is a rare childhood cancer developing from immature nerve cells. It is not caused by anything parents did during pregnancy. Diagnosis typically involves identifying early symptoms and performing a urine test for specific tumor markers (HVA and VMA).

Receiving a neuroblastoma diagnosis for your child is a moment of profound shock that can leave you feeling untethered. It is important to know that what you are feeling—fear, confusion, or even a sense of disbelief—is a natural response to an overwhelming situation [1].

A Developmental “Wrong Turn”

Neuroblastoma is not caused by anything you did or did not do during pregnancy or after your child was born [2][3]. Instead, it is a cancer that begins during a child’s early development, often before birth [4].

The disease originates in neural crest cells. These are a group of specialized cells in a developing embryo that are supposed to grow into various parts of the body, including the sympathetic nervous system [5][6]. The sympathetic nervous system is responsible for our “fight or flight” response, controlling involuntary actions like heart rate and blood pressure [7].

In children with neuroblastoma, some of these neural crest cells do not mature or “differentiate” into normal nerve cells as they should [6][8]. Instead, they continue to grow and divide, eventually forming a tumor [7]. Because these cells are part of the sympathetic nervous system, the tumors most commonly start in the adrenal glands (located on top of the kidneys) but can also appear anywhere along the nerve chains in the neck, chest, abdomen, or pelvis [9][7].

Symptoms: Connecting the Dots

Looking back, you may realize that the symptoms leading up to the diagnosis were vague and easy to confuse with normal childhood illnesses. Common presenting symptoms include:

  • An unusual lump or swelling in the abdomen (often noticed during a diaper change or bath).
  • Bone pain, which can cause a child to limp or refuse to walk.
  • Unexplained fevers, fatigue, or weight loss.
  • Bruising around the eyes (often called “raccoon eyes”), which happens if the cancer has spread to the bones around the eyes.

The First Tests: Urine Catecholamines

One of the primary ways doctors confirm and track neuroblastoma is through a specialized urine test [10]. Because neuroblastoma cells come from the sympathetic nervous system, they often overproduce chemicals called catecholamines.

Doctors look for two specific breakdown products of these chemicals in the urine: HVA (homovanillic acid) and VMA (vanillylmandelic acid) [10]. You will likely be asked to help collect your child’s urine (sometimes over a 24-hour period). These markers are essential for both the initial diagnosis and for continuously monitoring how well the treatment is working.

Why It Is Rare and Specialized

Neuroblastoma is the most common solid tumor found outside the skull in children [9]. However, in the broader context of healthcare, it is still considered a very rare disease. Roughly 7 to 10 children per million are diagnosed with neuroblastoma annually [11][12]. Because it is so rare, a general pediatrician may only see one or two cases in their entire career [13].

While your pediatrician may have been the one to first notice a symptom or an abdominal mass, the complexity of this disease requires a pediatric oncologist—a doctor who specializes in childhood cancers [10]. Shifting your child’s care to a major pediatric cancer center ensures they have access to the latest research and a multidisciplinary team dedicated to this specific disease [14][15].

Return to the Home Page.

Common questions in this guide

What causes neuroblastoma in children?
Neuroblastoma is a developmental cancer that begins early in a child's growth, often before birth. It happens when neural crest cells fail to mature into normal nerve cells and instead continue to grow into a tumor. It is not caused by anything a parent did or did not do during pregnancy.
What are the first signs and symptoms of neuroblastoma?
Early signs can be vague but often include an unusual lump or swelling in the abdomen, bone pain that may cause a child to limp, unexplained fevers, fatigue, or weight loss. Bruising around the eyes, sometimes called 'raccoon eyes,' can also occur.
Why does my child need a urine test for HVA and VMA?
Neuroblastoma tumors often overproduce chemicals called catecholamines. Doctors test your child's urine for HVA and VMA, which are the breakdown products of these chemicals, to confirm the diagnosis and track how well the treatment is working.
What kind of doctor treats neuroblastoma?
Because neuroblastoma is a rare and complex disease, your child's care should be managed by a pediatric oncologist. This specialist focuses exclusively on childhood cancers and coordinates with a multidisciplinary team at a specialized pediatric cancer center.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my child's tumor linked to a specific genetic marker, like MYCN amplification, and what does that tell us about its biology?
  2. 2.Will we need to collect a 24-hour urine sample to test for HVA and VMA, and how often will this be done?
  3. 3.Which specialists will be part of my child’s multidisciplinary care team?
  4. 4.Can you explain why neuroblastoma is considered a 'developmental' cancer rather than one caused by environmental factors?
  5. 5.What is the next step in confirming the exact stage and risk group of my child's neuroblastoma?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Beyond Treatment: Prevalence, Predictors, and Changes in Anxiety and Depression Among Parents of Childhood Cancer Survivors.

    Kurz H, Paul V, Nasse ML, et al.

    Psycho-oncology 2025; (34(3)):e70115 doi:10.1002/pon.70115.

    PMID: 40024877
  2. 2

    Epigenetic regulation of neuroblastoma development.

    Durinck K, Speleman F

    Cell and tissue research 2018; (372(2)):309-324 doi:10.1007/s00441-017-2773-y.

    PMID: 29350283
  3. 3

    Genetic predisposition and chromosome instability in neuroblastoma.

    Tonini GP, Capasso M

    Cancer metastasis reviews 2020; (39(1)):275-285 doi:10.1007/s10555-020-09843-4.

    PMID: 31927719
  4. 4

    Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma.

    Kerosuo L, Neppala P, Hsin J, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2018; (115(31)):E7351-E7360 doi:10.1073/pnas.1800039115.

    PMID: 30021854
  5. 5

    Origin and initiation mechanisms of neuroblastoma.

    Tsubota S, Kadomatsu K

    Cell and tissue research 2018; (372(2)):211-221 doi:10.1007/s00441-018-2796-z.

    PMID: 29445860
  6. 6

    Chromaffin Cells with Sympathoblast Signature: Too Similar to Keep Apart?

    Bedoya-Reina OC, Schlisio S

    Cancer cell 2021; (39(2)):134-135 doi:10.1016/j.ccell.2020.12.009.

    PMID: 33385330
  7. 7

    Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma.

    Dong R, Yang R, Zhan Y, et al.

    Cancer cell 2020; (38(5)):716-733.e6 doi:10.1016/j.ccell.2020.08.014.

    PMID: 32946775
  8. 8

    Lineage-restricted sympathoadrenal progenitors confer neuroblastoma origin and its tumorigenicity.

    Yang CL, Serra-Roma A, Gualandi M, et al.

    Oncotarget 2020; (11(24)):2357-2371 doi:10.18632/oncotarget.27636.

    PMID: 32595833
  9. 9

    Pediatric neuroblastic tumors: A critical evaluation of cytomorphological features for risk stratification on aspiration cytology.

    Behera G, Chhabra G, Mishra P, Sable M

    Diagnostic cytopathology 2020; (48(5)):464-474 doi:10.1002/dc.24389.

    PMID: 32043835
  10. 10

    Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review.

    Mora J

    Cancers 2022; (14(11)) doi:10.3390/cancers14112572.

    PMID: 35681553
  11. 11

    Global, regional, and national epidemiology of childhood neuroblastoma (1990-2021): a statistical analysis of incidence, mortality, and DALYs.

    Nong J, Su C, Li C, et al.

    EClinicalMedicine 2025; (79()):102964 doi:10.1016/j.eclinm.2024.102964.

    PMID: 39720601
  12. 12

    Global, regional and national burden of neuroblastoma and other peripheral nervous system tumors, 1990 to 2021 and predictions to 2035: visualizing epidemiological characteristics based on GBD 2021.

    Yue C, Zhang Q, Sun F, Pan Q

    Neoplasia (New York, N.Y.) 2025; (60()):101122 doi:10.1016/j.neo.2025.101122.

    PMID: 39855015
  13. 13

    Neurologic disorders in long-term survivors of neuroblastoma - a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) research program.

    Norsker FN, Rechnitzer C, Andersen EW, et al.

    Acta oncologica (Stockholm, Sweden) 2020; (59(2)):134-140 doi:10.1080/0284186X.2019.1672892.

    PMID: 31591921
  14. 14

    Metastasis pattern and prognosis in children with neuroblastoma.

    Liu S, Yin W, Lin Y, et al.

    World journal of surgical oncology 2023; (21(1)):130 doi:10.1186/s12957-023-03011-y.

    PMID: 37046344
  15. 15

    High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition.

    Cai J, Jacob S, Kurupi R, et al.

    Cell reports 2022; (40(4)):111095 doi:10.1016/j.celrep.2022.111095.

    PMID: 35905710

This page provides educational information about neuroblastoma for parents and caregivers. It is for informational purposes only and does not replace professional medical advice from your child's pediatric oncologist.

Get notified when new evidence is published on Neuroblastoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.